Barton Shane (CIK 1836297) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy BIOA (9,301 shares), Buy BIOA (7,261 shares), Buy BIOA (8,958 shares), Buy BIOA (14,198 shares), Sell BIOA (42,350 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 9,301 | $100,916 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 7,261 | $60,920 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 8,958 | $38,519 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 14,198 | $62,187 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Sell | 42,350 | $1.1M |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 4,290 | $46,546 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 4,000 | $33,560 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 4,065 | $17,480 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 7,861 | $34,431 |
| 2026-07-01 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Sell | 20,216 | $509,176 |
| 2025-03-10 | BioAge Labs, Inc. (BIOA) | Principal Accounting Officer | Buy | 2,632 | $47,376 |
Source: SEC Form 4 filings · as of 2026-07-01